COVID's origins: what we do and don't know.  Venter M, Manuguerra JC, Watson JM, Fischer TK, Blacksell SD, Summermatter K, Damon IK, Drosten C, Alviola P, Assiri A, Farag E, Gangakhedkar R, Ghosn N, Guzman MG, Happi C, Kalema-Zikusoka G, Labbé…

Kommentar von Prof. Dr. med. Klaus Überla: Coronapandemie — Fünf Jahre COVID-19-Impfung Im Dezember 2020 erfolgte die erste COVID-19-Impfung. Inzwischen wurden mehr als 200 Millionen Impfdosen in Deutschland verabreicht und zahlreiche Studien veröf…

Clinical outcomes from a mid-western opioid treatment program during covid-19 emergency regulations: a brief report on the effect of tetrahydrocannabinol (THC) use on take home methadone access.  LaCourt ET, Ibekie O, Dike CC, Jegede O. …

Narrative Review of Opioid Use Disorder Treatment Changes During the COVID-19 Pandemic and Their Impact on American Indian/Alaska Native Communities.  Bingham-Hendricks C, Peters-Mosquera A, Aronowitz SV, Woods C, Aronowitz T.  Nurs Open…

Adapting opioid therapy: real-world analysis of switching from methadone to slow-release morphine and back amid COVID-19 supply chain disruptions.  Barkus A, Subata E, Jakavičius H, Barkienė L, Lydekaitė E, Zdanavičius L, Likatavičius G, Širvi…

Rurality weakens the positive association between the COVID-19 pandemic and substance use treatment involving medications for opioid use disorder.  Lofaro RJ, Confer LM, Bohler RM, Schwind JS.  Drug Alcohol Depend Rep. 2026 Jan 5;18:1004…